| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/VIRO.1993.1003 |
| P698 | PubMed publication ID | 8390752 |
| P2093 | author name string | Wood D | |
| Almond JW | |||
| Minor PD | |||
| Pollard SR | |||
| Ferguson G | |||
| Macadam AJ | |||
| Skuce R | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| Poliovirus | Q70923324 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 18-26 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates | |
| P478 | volume | 192 |
| Q37002529 | A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus |
| Q41897207 | A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection |
| Q34435032 | Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties |
| Q28478276 | Antiviral activity of 3(2H)- and 6-chloro-3(2H)-isoflavenes against highly diverged, neurovirulent vaccine-derived, type2 poliovirus sewage isolates |
| Q27469644 | Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3 |
| Q24682487 | Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 |
| Q33310740 | Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar |
| Q39658921 | Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains |
| Q80259936 | Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine |
| Q35845137 | Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine |
| Q48062112 | Determination of antigenic properties of vaccine derived poliovirus strains |
| Q90699187 | Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization |
| Q39446202 | Direct detection of Sabin poliovirus vaccine strains in stool specimens of first-dose vaccinees by a sensitive reverse transcription-PCR method. |
| Q50042232 | Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak |
| Q47278425 | Emergence of Vaccine-Derived Polioviruses during Ebola Virus Disease Outbreak, Guinea, 2014-2015. |
| Q52655516 | Emergency Services of Viral RNAs: Repair and Remodeling. |
| Q36577059 | Environmental Surveillance of Polioviruses in Rio de Janeiro, Brazil, in Support to the Activities of Global Polio Eradication Initiative |
| Q37110431 | Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina |
| Q35075110 | Environmental surveillance of poliovirus in sewage water around the introduction period for inactivated polio vaccine in Japan |
| Q21245132 | Epidemics to eradication: the modern history of poliomyelitis |
| Q39106052 | Exchanges of genomic domains between poliovirus and other cocirculating species C enteroviruses reveal a high degree of plasticity. |
| Q33780697 | Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells |
| Q37355985 | Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons. |
| Q38442337 | Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization. |
| Q33804871 | Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region. |
| Q37336380 | Highly divergent type 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia |
| Q92881586 | Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises |
| Q33346729 | Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus |
| Q34005217 | Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes |
| Q50624426 | Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child. |
| Q33899399 | Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China. |
| Q28082036 | Live attenuated vaccines: Historical successes and current challenges |
| Q35845480 | Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus |
| Q35382314 | Mechanisms controlling virulence thresholds of mixed viral populations |
| Q34143845 | Mechanisms of genetic variation in polioviruses |
| Q34545765 | Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region. |
| Q35971462 | Molecular and Phenotypic Characterization of a Highly Evolved Type 2 Vaccine-Derived Poliovirus Isolated from Seawater in Brazil, 2014. |
| Q33969974 | Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. |
| Q36760045 | Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria |
| Q34026234 | Nonhomologous recombination between defective poliovirus and coxsackievirus genomes suggests a new model of genetic plasticity for picornaviruses |
| Q38087428 | Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs). |
| Q58094266 | Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis |
| Q42062444 | Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. |
| Q81923823 | Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa |
| Q40243124 | Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication |
| Q33438422 | Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses |
| Q43088422 | Reemergence of recombinant vaccine-derived polioviruses in healthy children, Madagascar |
| Q33784783 | Reverse genetics of picornaviruses |
| Q35851911 | Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus |
| Q37333852 | Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine |
| Q37743865 | Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine |
| Q37201841 | The pathogenesis of poliomyelitis: what we don't know |
| Q92592753 | The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study |
| Q46602654 | The substitution U475 --> C with Sabin3-like mutation within the IRES attenuate Coxsackievirus B3 cardiovirulence |
| Q24647825 | Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence |
| Q90666972 | Translational Control of the Picornavirus Phenotype |
Search more.